Literature DB >> 14611121

Growth patterns in juvenile rheumatoid arthritis.

J J Liem1, A M Rosenberg.   

Abstract

OBJECTIVE: To define patterns of growth in juvenile rheumatoid arthritis (JRA) and to evaluate possible associated clinical and laboratory correlates.
METHODS: The study population comprised 67 children with JRA who had been followed for 5 years or longer and whose follow-up period did not extend beyond 18 years of age. Height and weight z scores were calculated with reference to age-related standards for each of the annual follow-up intervals and correlated with JRA subtype, the presence of rheumatoid factor (RF), the erythrocyte sedimentation rate (ESR), alkaline phosphatase level (ALP) and medication history.
RESULTS: Initial height-for-age (HAZ) scores for pauciarticular, polyarticular and systemic JRA onset groups (PaJRA, PoJRA and SJRA respectively) were +0.27, -0.07 and +0.40 respectively. A significantly lower HAZ score in the SJRA population compared to the PaJIA population first became apparent at year 2 and the difference was maintained throughout the 9-year follow-up period. A significantly lower HAZ score in the SJRA population compared to the PoJRA population first became apparent at year 6 and the difference was maintained until the ninth year. During the 9-year follow-up period, RF-positive children tended to have negative HAZ scores whereas RF-negative children tended to have positive HAZ scores. The SJRA onset group displayed significantly lower HAZ scores, as compared to the HAZ score at onset, for 7 of the 9 subsequent follow-up intervals. Only 2 patients had heights < 2SD below the mean at final determination. Delay in generalized linear growth occurred predominantly in the SJRA population and to a lesser degree in those with PoJRA associated with RF positivity.
CONCLUSIONS: Delay in linear growth occurs in some children with JRA. Patients with pauciarticular and RF-negative polyarticular disease can have growth patterns similar to normal children. Children with RF-positive polyarticular and systemic JRA have more significant growth retardation that occasionally can be sustained and extreme.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611121

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  11 in total

Review 1.  Growth abnormalities in children and adolescents with juvenile idiopathic arthritis.

Authors:  Susanne Bechtold; Dominique Simon
Journal:  Rheumatol Int       Date:  2014-04-24       Impact factor: 2.631

Review 2.  The Emerging Role of Glucose Metabolism in Cartilage Development.

Authors:  Judith M Hollander; Li Zeng
Journal:  Curr Osteoporos Rep       Date:  2019-04       Impact factor: 5.096

3.  Are Indian patients with juvenile-onset ankylosing spondylitis taller than reference population ?

Authors:  Pulukool Sandhya; Debashish Danda; Lakshmanan Jeyaseelan
Journal:  Indian J Med Res       Date:  2015-04       Impact factor: 2.375

4.  Protective effects of C-type natriuretic peptide on linear growth and articular cartilage integrity in a mouse model of inflammatory arthritis.

Authors:  Hülya Bükülmez; Fozia Khan; Cynthia F Bartels; Shunichi Murakami; Adriana Ortiz-Lopez; Abdus Sattar; Tariq M Haqqi; Matthew L Warman
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

5.  Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort.

Authors:  Jaime Guzman; Tristan Kerr; Leanne M Ward; Jinhui Ma; Kiem Oen; Alan M Rosenberg; Brian M Feldman; Gilles Boire; Kristin Houghton; Paul Dancey; Rosie Scuccimarri; Alessandra Bruns; Adam M Huber; Karen Watanabe Duffy; Natalie J Shiff; Roberta A Berard; Deborah M Levy; Elizabeth Stringer; Kimberly Morishita; Nicole Johnson; David A Cabral; Maggie Larché; Ross E Petty; Ronald M Laxer; Earl Silverman; Paivi Miettunen; Anne-Laure Chetaille; Elie Haddad; Lynn Spiegel; Stuart E Turvey; Heinrike Schmeling; Bianca Lang; Janet Ellsworth; Suzanne E Ramsey; Johannes Roth; Sarah Campillo; Susanne Benseler; Gaëlle Chédeville; Rayfel Schneider; Shirley M L Tse; Roxana Bolaria; Katherine Gross; Debbie Feldman; Bonnie Cameron; Roman Jurencak; Jean Dorval; Claire LeBlanc; Claire St Cyr; Michele Gibbon; Rae S M Yeung; Ciarán M Duffy; Lori B Tucker
Journal:  Pediatr Rheumatol Online J       Date:  2017-08-22       Impact factor: 3.054

6.  Low Serum IGF-1 in Boys with Recent Onset of Juvenile Idiopathic Arthritis.

Authors:  Anna-Carin Lundell; Malin Erlandsson; Maria Bokarewa; Hille Liivamägi; Karin Uibo; Sirje Tarraste; Tiina Rebane; Tiina Talvik; Chris Pruunsild; Rille Pullerits
Journal:  J Immunol Res       Date:  2018-11-28       Impact factor: 4.818

7.  Validity and feasibility of the self-report EQ-5D-Y as a generic Health-Related Quality of Life outcome measure in children and adolescents with Juvenile Idiopathic Arthritis in Western Cape, South Africa.

Authors:  Desiree Scott; Christiaan Scott; Jennifer Jelsma; Deepthi Abraham; Janine Verstraete
Journal:  S Afr J Physiother       Date:  2019-07-30

8.  Dental age estimation in children affected by juvenile rheumatoid arthritis.

Authors:  Vilma Pinchi; Ilenia Bianchi; Francesco Pradella; Giulia Vitale; Martina Focardi; Ingrid Tonni; Luigi Ferrante; Andrea Bucci
Journal:  Int J Legal Med       Date:  2020-08-20       Impact factor: 2.686

Review 9.  Growth abnormalities in children with type 1 diabetes, juvenile chronic arthritis, and asthma.

Authors:  Cosimo Giannini; Angelika Mohn; Francesco Chiarelli
Journal:  Int J Endocrinol       Date:  2014-02-04       Impact factor: 3.257

10.  Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS).

Authors:  Flora McErlane; Roberto Carrasco; Lianne Kearsley-Fleet; Eileen M Baildam; Lucy R Wedderburn; Helen E Foster; Yiannis Ioannou; S E Alice Chieng; Joyce E Davidson; Wendy Thomson; Kimme L Hyrich
Journal:  Semin Arthritis Rheum       Date:  2017-11-07       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.